CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Memantine hydrochloride

Last Updated: December 21, 2004
Result type: Reports
Project Number: SR0025-000
Product Line: Reimbursement Review

Generic Name: Memantine hydrochloride

Brand Name: Ebixa

Manufacturer: Lundbeck Canada Inc.

Therapeutic Area: Dementia (Alzheimer type), moderate to severe

Indications: Dementia (Alzheimer type), moderate to severe

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: November 23, 2005

Recommendation Type: Do not list